Bringing CRISPR out of the Lab to Democratize Diagnostics

Bringing CRISPR out of the Lab to Democratize Diagnostics

Bringing CRISPR out of the Lab to Democratize Diagnostics
We hope that you enjoyed hearing from industry leaders about how they are working to expedite therapy development, incorporate digital therapeutics at scale, and improve patient outcomes. For more information on other ways AWS can help your healthcare and life sciences organization, visit us at: https://amzn.to/2LK072h or contact the team at: [email protected]

Mammoth Biosciences’ vision is to provide a CRISPR-based platform on which an infinite number of tests can be built by both ourselves and our partners – democratizing access to an endless variety of tests for bio sensing in healthcare, as well as across industries such as agriculture, manufacturing, forensics, and more.

View on YouTube

Sharing is caring!

Comments are closed.